MAPFRE is tracked as an insurer group, headquartered in Spain. MAPFRE qualifies because the group identity, reporting, earnings, rating, and exchange source paths are stable enough for a source-reading guide. This guide should explain source type and group boundary rather than make ranking, valuation, product, pricing, or advice claims.
Source-reviewed company references
MAPFRE: Annual earnings presentation 2025
Supports results-period context and source-owner evidence.
Why it matters: This card anchors the results/earnings part of the MAPFRE source pack and preserves the stated disclosure scope.
HTTP 200 verified 2026-07-10. Presentation metrics must not be restated without exact denominator and period.
Results presentation is not a forecast or advice source.
MAPFRE: Financial documentation center
Supports annual-report and financial-document source basis.
Why it matters: This card anchors the annual report/financial documentation part of the MAPFRE source pack and preserves the stated disclosure scope.
HTTP 200 verified 2026-07-10. Use only report-stated currency, segment, and period in later seeds.
Library pages can mix reports and presentations.
MAPFRE: MAPFRE, S.A. listing
Supports public listing/source-path context.
Why it matters: This card anchors the exchange/listing part of the MAPFRE source pack and preserves the stated disclosure scope.
HTTP 200 after redirect verified 2026-07-10. Do not cite price, performance, valuation, or investment conclusions.
Exchange listing is not operating insurance evidence.
MAPFRE: Ratings
Supports rating-source trail.
Why it matters: This card anchors the official rating page part of the MAPFRE source pack and preserves the stated disclosure scope.
HTTP 200 verified 2026-07-10. Do not convert ratings into recommendations, rankings, or solvency conclusions.
Ratings are third-party opinions presented by MAPFRE.
Full company reference archive
View the complete source-reviewed company reference archive, including reporting periods, source dates, reviewed dates, methodology notes, reader cautions, and official source links.
Business And Entity Overview
Qualifies with official financial-documentation, earnings, ratings, share, and BME listing support. The profile is bounded to MAPFRE, S.A and the consolidated or parent scope identified by each source. It does not transfer group figures automatically to every licensed insurer, branch, brand, or other subsidiary.
Source-Reviewed Evidence
- Financial documentation center (FY2025 library path). Supports annual-report and financial-document source basis. Scope: MAPFRE group. Caution: Library pages can mix reports and presentations.
- Annual earnings presentation 2025 (FY2025). Supports results-period context and source-owner evidence. Scope: MAPFRE group. Caution: Results presentation is not a forecast or advice source.
- Ratings (Current rating page). Supports rating-source trail. Scope: MAPFRE group / rated entities as listed. Caution: Ratings are third-party opinions presented by MAPFRE.
- MAPFRE, S.A. listing (Current listing page). Supports public listing/source-path context. Scope: Listed security. Caution: Exchange listing is not operating insurance evidence.
Entity Boundary
Treat MAPFRE as a listed insurance group; do not overstate subsidiary-level underwriting, pricing, or product availability from group-level sources.
Lines And Geographic Context
The reviewed source pack supports connections to Property and Casualty, Life and Health, Reinsurance. Spain is the home-jurisdiction reference; other geographies require their own segment or legal-entity support.
Why This Profile Exists
Keeping the 4 reviewed source cards together gives readers a stable route from corporate identity to periodic reporting, capital or regulatory context, and public listing or profile evidence. The profile does not present a score, comparison table, or commercial recommendation.
Reader Note
This profile is source-led reference material. Periodic figures retain the source's metric label, unit, reporting period, and entity scope. Ratings, regulatory measures, listing records, and issuer-defined measures are contextual evidence, not standalone judgments about financial strength, suitability, security value, product choice, pricing, or available insurance capacity.